Diamyd_logo
FDA Approves Diamyd Vaccine Study In Children As Young As 3
Diamyd Medical, a Swedish diabetes company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, reports today that the US FDA has approved the experimental use of Diamyd® vaccine in children as young as 3 years of age in the TrialNet GAD study, enrolling 126 new onset type 1 diabetes patients in North America...
Zucchini Latkes
Zucchini Latkes
This simple Zucchini Latkes recipe replaces potatoes with low-carb zucchini, so we can enjoy a traditional Hanukkah dish without the risk of a major blood sugar spike.
JDRF New Logo
First Treatment For Diabetic Related Eye Disease May Soon Be Available
According to a JDRF press release great progress has been made towards finding a treatment for diabetes-related eye disease. Novartis Pharmaceuticals, based in Switzerland, announced that the drug Lucentis has been submitted to the European Union's regulatory agency, European Medicines Agency, for approval for the treatment of diabetic macular edema...
Dorking Out, Diabetes-style
I’m about to head into San Francisco to have coffee with Amy Tenderich of DiabetesMine (she lives nearby in the Bay Area) — and I have…
Diabetes_UK_Logo
Diabetes UK to Fund New Diabetes Research
Diabetes UK announced that it would be dedicating almost £750,000 ($1,200,000) to four new research projects looking to understand the causes of diabetes, help with its day-to-day management and protect against its complications. "We are delighted to be supporting this new research and hope that it will bring benefit and improvements for people living...
What A Diabetic Sees When She Sees Circles
I’m immensely interested in cosmology.  Headlines like this one, “The Circular Logic of The Unvierse,” in the NYT are sure to pull me in.   I won’t…
Type 1 Diabetes and Congress’s To-Do List
Recently, Congress has been getting a lot of attention for how hard its members are supposedly working. They’re staying in Saturdays to…
Eli Lilly Logo
Eli Lilly Announces The First 300-Unit Vial of Insulin
Eli Lilly and Company announced the availability of a smaller vial of insulin containing 3 mL (300 units), the first such vial in the United States. A typical vial of insulin contains 10 mL, or 1,000 "units" of insulin. Lilly developed this new smaller vial for use in hospitals based on feedback regarding the average duration of patient hospital stays.